Cwm, LLC Exelixis, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Cwm, LLC holds 34,643 shares of EXEL stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,643

Previous 19,988 73.32%

Holding current value

$1.17 Million

Previous $449,000 100.22%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$21.96 - $27.6 $321,823 - $404,478	14,655 Added 73.32%	34,643 $899,000
Q2 2024 Jul 09, 2024	BUY	$20.34 - $23.73 $87,482 - $102,062	4,301 Added 27.42%	19,988 $449,000
Q1 2024 Apr 05, 2024	BUY	$20.17 - $23.93 $111,156 - $131,878	5,511 Added 54.16%	15,687 $372,000
Q4 2023 Feb 01, 2024	BUY	$19.25 - $24.13 $47,701 - $59,794	2,478 Added 32.19%	10,176 $244,000
Q3 2023 Oct 11, 2023	BUY	$19.04 - $22.74 $21,629 - $25,832	1,136 Added 17.31%	7,698 $168,000
Q2 2023 Aug 03, 2023	BUY	$18.17 - $20.48 $944 - $1,064	52 Added 0.8%	6,562 $125,000
Q1 2023 Apr 28, 2023	BUY	$16.3 - $19.41 $11,638 - $13,858	714 Added 12.32%	6,510 $126,000
Q4 2022 Feb 01, 2023	SELL	$14.96 - $17.39 $3,844 - $4,469	-257 Reduced 4.25%	5,796 $93,000
Q3 2022 Oct 27, 2022	BUY	$15.68 - $22.27 $10,772 - $15,299	687 Added 12.8%	6,053 $95,000
Q2 2022 Jul 28, 2022	BUY	$17.44 - $23.16 $3,993 - $5,303	229 Added 4.46%	5,366 $112,000
Q1 2022 Apr 21, 2022	BUY	$17.03 - $22.67 $7,833 - $10,428	460 Added 9.84%	5,137 $116,000
Q1 2021 Sep 15, 2021	BUY	$20.53 - $25.22 $2,258 - $2,774	110 Added 2.41%	4,677 $85,000
Q1 2021 Apr 27, 2021	SELL	$20.53 - $25.22 $2,258 - $2,774	-110 Reduced 2.35%	4,567 $103,000
Q4 2020 Sep 15, 2021	BUY	$18.39 - $24.8 $2,022 - $2,728	110 Added 2.41%	4,677 $85,000
Q4 2020 Jan 27, 2021	SELL	$18.39 - $24.8 $2,022 - $2,728	-110 Reduced 2.35%	4,567 $92,000
Q3 2020 Sep 15, 2021	BUY	$20.67 - $26.94 $2,273 - $2,963	110 Added 2.41%	4,677 $85,000
Q3 2020 Oct 19, 2020	SELL	$20.67 - $26.94 $2,273 - $2,963	-110 Reduced 2.35%	4,567 $112,000
Q2 2020 Sep 15, 2021	BUY	$16.46 - $27.42 $1,810 - $3,016	110 Added 2.41%	4,677 $85,000
Q2 2020 Jul 22, 2020	SELL	$16.46 - $27.42 $1,810 - $3,016	-110 Reduced 2.35%	4,567 $108,000
Q1 2020 Sep 15, 2021	BUY	$14.46 - $21.8 $1,590 - $2,398	110 Added 2.41%	4,677 $85,000
Q1 2020 Apr 28, 2020	SELL	$14.46 - $21.8 $1,590 - $2,398	-110 Reduced 2.35%	4,567 $79,000
Q4 2019 Sep 14, 2021	BUY	$15.15 - $18.89 $2,681 - $3,343	177 Added 3.93%	4,677 $85,000
Q4 2019 Jan 27, 2020	SELL	$15.15 - $18.89 $2,681 - $3,343	-177 Reduced 3.78%	4,500 $79,000
Q3 2019 Sep 14, 2021	BUY	$17.68 - $22.65 $1,290 - $1,653	73 Added 1.59%	4,677 $85,000
Q3 2019 Oct 22, 2019	SELL	$17.68 - $22.65 $1,290 - $1,653	-73 Reduced 1.56%	4,604 $81,000
Q2 2019 Sep 14, 2021	SELL	$18.93 - $24.75 $8,083 - $10,568	-427 Reduced 8.37%	4,677 $85,000
Q2 2019 Jul 31, 2019	BUY	$18.93 - $24.75 $8,083 - $10,568	427 Added 9.13%	5,104 $109,000
Q1 2019 Sep 02, 2021	SELL	$19.6 - $24.76 $10,231 - $12,924	-522 Reduced 10.04%	4,677 $0
Q1 2019 Apr 22, 2019	BUY	$19.6 - $24.76 $2,038 - $2,575	104 Added 2.04%	5,199 $124,000
Q4 2018 Jan 25, 2019	BUY	$13.65 - $21.8 $1,296 - $2,071	95 Added 1.9%	5,095 $100,000
Q3 2018 Oct 29, 2018	BUY	$15.87 - $22.4 $79,350 - $112,000	5,000 New	5,000 $89,000
Q1 2018 Apr 26, 2018	SELL	$22.15 - $31.89 $3,721 - $5,357	-168 Closed	0 $0
Q3 2017 Oct 16, 2017	BUY	$23.35 - $29.24 $3,922 - $4,912	168	168 $4,000

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account